Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Why Clinicians Make Great MSLs
Summary
In this episode, Tom Caravela is joined by Dawn O'Reilly, who shares her journey into the MSL role and offers valuable insights for clinicians transitioning into this field. Dawn discusses why clinicians are well-suited for MSL positions and provides advice for those making the switch. She reflects on lessons learned, emphasizing the importance of patience and the skills necessary for new MSLs. The conversation also covers the unique challenges of navigating the MSL role during the pandemic and the shift to virtual work. Dawn concludes with her future aspirations and the significance of mentoring, encouraging listeners to pursue their goals.
Dawn O'Reilly, Ph.D., MMS, PA-C, Medical Science Liaison at Biodesix discusses why and how clinicians make great Medical Science Liaisons
Dawn shares…
π Tips and advice to transition to an MSL role
π What skills clinicians need to develop for industry roles
π The importance of networking in your career and job search
π What challenges you can expect as an MSL
π Why patience is so critical
Medical Science Liaison, MSL role transition, clinician to MSL, networking for MSLs, MSL career advice
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary